Tharimmune, Inc.
General ticker "THAR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $40.6M (TTM average)
Tharimmune, Inc. does not follow the US Stock Market performance with the rate: -14.5%.
Estimated limits based on current volatility of 1.8%: low 1.90$, high 1.97$
Factors to consider:
- Total employees count: 2 as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Regulatory and compliance, Commercialization challenges, Crypto volatility, Litigation risks, Financing availability
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.61$, 5.59$]
- 2026-12-31 to 2027-12-31 estimated range: [0.87$, 3.32$]
Financial Metrics affecting the THAR estimates:
- Positive: with PPE of -1.0 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -18.61 <= 0.30
- Positive: Shareholder equity ratio, % of 76.65 > 63.79
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: negative Industry operating cash flow (median)
Short-term THAR quotes
Long-term THAR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $9.46MM | $12.43MM | $20.11MM |
| Operating Income | $-9.46MM | $-12.43MM | $-20.11MM |
| Non-Operating Income | $0.14MM | $0.24MM | $-22.00MM |
| Interest Expense | $0.02MM | $0.01MM | $0.03MM |
| R&D Expense | $3.56MM | $6.39MM | $3.07MM |
| Income(Loss) | $-9.32MM | $-12.20MM | $-42.10MM |
| Taxes | $0.00MM | $0.00MM | $-6.19MM |
| Net Income(Loss)* | $-9.32MM | $-12.20MM | $-35.92MM |
| Stockholders Equity | $9.13MM | $1.31MM | $397.93MM |
| Assets | $10.95MM | $3.72MM | $519.15MM |
| Operating Cash Flow | $-7.30MM | $-10.90MM | $-16.13MM |
| Investing Cash Flow | $0.00MM | $0.00MM | $-77.57MM |
| Financing Cash Flow | $11.72MM | $3.53MM | $107.17MM |
| Earnings Per Share** | $-107.08 | $-9.41 | $-1.12 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.